Many factors determine the health of your heart and blood vessels, especially a balanced diet low in fat and high in fiber. Sometimes we don't eat the foods that give us the nutrients we need to support optimal cardiovascular health. These nutrients include the lipotropic factors choline and inositol, and the B-vitamins.
Lipotropic factors help keep lipids (fats) emulsified in blood, so they may be mobilized and utilized throughout the body where needed. B-vitamins help assure proper metabolism of homocysteine, a natural metabolic by-product that can damage arteries if it accumulates. GNLD NeoLife leading-edge vitamin supplement Lipotropic Adjunct™ provides nutrients shown to play essential roles in supporting the health of the circulatory system.
The Homocysteine Story:
In 1966, Dr. Kilmer S. McCully made the initial observation that linked high blood levels of homocysteine to diseases of the blood vessels. Remarkably consistent findings from more than 20 research studies indicate that patients who have had strokes, heart attacks, or other forms of cardiovascular disease tend to have higher homocysteine levels than people without disease.(1)
In Harvard's Physicians Health Study, men whose homocysteine levels were in the highest 5% had triple the risk of having a heart attack compared to those with lower levels.(2)
In a group of elderly Framingham Heart Study participants, narrowing of carotid arteries was twice as prevalent in those with the highest homocysteine levels compared to those with the lowest, after adjustment for sex, age, cholesterol, blood pressure, and smoking.(3) The lower the folate and vitamin B6 levels, the greater the prevalence of narrowed arteries.
Benefits of GNLD's Lipotropic Adjunct™:
Lipotropic factors, choline and inositol, help keep lipids (fats) emulsified in the bloodstream and help reduce the buildup of unwanted fat in the liver. Folic acid, B6 and B12 promote proper metabolism of homocysteine, which supports a healthy antioxidant response to LDL cholesterol, free flowing circulation and overall arterial wall health. ***
Concentrated formula of lipotropic factors provides nutritional assistance in the mobilization and utilization of dietary fats. ***
GNLD NeoLife Lipotropic Adjunct™ vitamin supplement's complete formula includes choline, inositol, betaine, folic acid, and vitamins B6 and B12; all are nutrients which support the body's own synthesis of lipotropic factors and are key elements for the proper metabolism and elimination of homocysteine, a potent oxidant. ***
Enhanced vitamin B12 digestion and bioavailability is provided by natural betaine. ***
GNLD NeoLife Lipotropic Adjunct™ vitamin supplement supports proper capillary function, important for carrying blood lipids throughout body tissues, is provided by citrus bioflavonoids and hesperidin from grapefruit. ***
What is the difference between GNLD's B-Complex and Lipotropic Adjunct™?
GNLD's Vitamin B-Complex contains some of the same elements as Lipotropic Adjunct™. However, Lipotropic Adjunct™, even at the lowest suggested dosage of two tablets daily, contains additional vitamin B12, choline, and betaine HCl to better support the homocysteine cycle. At the higher suggested dosage of four tablets daily, Lipotropic Adjunct™ contains substantial additional support for lipid mobilization and homocysteine metabolism. The nutrient levels in Lipotropic Adjunct™ are consistent with the majority of research on the homocysteine cycle and were specifically chosen to be sufficient to prevent homocysteine accumulation. Our Lipotropic Adjunct™ is targeted directly at homocysteine and heart health, while the B vitamins found in our Vitamin B-Complex address a broader application within the body, filling a far more general range of needs.
Read the Fast Facts
about Lipotropic Adjunct™
Read the Product Brochure
on Lipotropic Adjunct™
(1) Ueland, P.M., Refsum, H. and Brattstrîm, L. Plasma Homocysteine and Cardiovascular Disease. In: Francis, R.B., Jr., ed. Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. New York: Marcel Dekker, 183–236, 1992.
(2) Stampfer, M.J., Malinow, M.R., Willett, W.C., et al. A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in U.S. Physicians. JAMA 268:877–881, 1992.
(3) Selhub, J., Jacques, P.F., Bostom, A.G., D’Agostino, R.B., Wilson, P.W.F., Belanger, A.J., O'Leary, D.H., Wolf, P.A., Schaefer, E.J. and Rosenberg, I.H. Association Between Plasma Homocysteine Concentrations and Extracranial Carotid-artery
Stenosis. New Engl. J. Med. 332:286–291, 1995.